Company Active LTD

Company profile

Binx Health Limited

UK company 05513139, incorporated on 19 July 2005.

Fast and convenient diagnostic solutions | binx health

Binx Health Limited is a UK company with status active founded in 2005 based in South West England.

Company number
05513139
Incorporated
19 Jul 2005
Companies House status
Active

Company identity

Founded / incorporated
19 July 2005

Company number 05513139

Verify at Companies House
Legal name
BINX HEALTH LIMITED
Company type
LTD
Region
South West England
Registered address
Unknown
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

1 event
19 Jul
2005

Incorporated

Inception

Company registered at Companies House

Public funding

4 awards
First funded
2010
Funded years
2010, 2012, 2016, 2017
Age at first award
5 years

Projects

2017 Small Business Research Initiative Lead participant

A stratified medicine diagnostic test for STI patients at the point-of-care

1 Jun 2017 to 31 Mar 2020

Awarded
£1,998,984
Total cost £1,998,984

A rapid stratified medicine diagnostic test for STI patients at the point-of-care. Atlas Genetics are developing a rapid, multi-pathogen, point-of-care (POC) diagnostic test for patients presenting at sexual health clinics, to enable the stratification of these patients, allowing sexual health professionals to direct immediate and effective treatment base...

2016 Small Business Research Initiative Lead participant

A Rapid Stratified Medicine Diagnostic Test To Direct Treatment For Symptomatic

1 Mar 2016 to 30 Nov 2016

Awarded
£149,915
Total cost £149,915

A Rapid Stratified Medicine Diagnostic Test To Direct Treatment For Symptomatic Patients Presenting In Sexual Health Clinics Atlas Genetics will develop a rapid point-of-care (PoC) stratified medicine diagnostic (SMD) for patients presenting to Sexual Health Clinics with genital discharge syndrome, to allow immediate and accurate selection of appropriate ...

2012 Collaborative R&D

Molecular Prognostic Test for Sepsis for use in Point of Care Setting

1 Jul 2012 to 31 Dec 2014

Awarded
£160,910
Total cost £268,182

Diagnosis of SIRS & sepsis and identification of patients likely to progress to severe sepsis or septic shock is challenging due to a lack of definitive diagnostic tests. This project aims to identify biomarker panels for diagnosis and prognosis of SIRS, sepsis and likely progression to severe sepsis from patient host biomarkers identified in previously p...

2010 Collaborative R&D Lead participant

Development of an ultra-rapid, point-of care diagnostic system for Chlamydia and gonorrhoea

1 Nov 2010 to 31 May 2015

Awarded
£1,072,364
Total cost £2,144,727

This project is to develop a system for ultra-rapid and highly sensitive, DNA-based Point-Of-Care tests for Chlamydia and gonorrhoea. The system will use a disposable cartridge for testing a patient sample which will be processed using a low cost reader instrument. The system will have innovative features ensuring ease of use & accuracy which include: • a...

Product types

Collaborative R&D Small Business Research Initiative